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Summary The extent to which a doctor or health professional can make a valid assessment of a patient's
quality of life, anxiety and depression was investigated in a series of cancer patients. Doctors and patients
filled out the same forms, viz. the Karnofsky, Spitzer, Linear Analogue Self Assessment Scales and a series of
simple scales designed for this study, at the same time. Correlations between the two sets of scores were poor,
suggesting that the doctors could not accurately determine what the patients felt. A further study examining
the reproducibility of these scales demonstrated considerable variability in results between different doctors. It
is concluded that if a reliable and consistent method of measuring quality of life in cancer patients is required,
it must come from the patients themselves and not from their doctors and nurses.
What constitutes quality of life is a personal and individual
question which lends itself to a philosophical rather than a
scientific approach. The need to objectively measure quality
of life during clinical trials of anti-cancer therapy is,
however, widely recognised, as treatment is often toxic and is
frequently given with palliative rather than curative intent.
Several instruments have been developed to quantitate these
subjective parameters (Coates et al., 1983; Gough et al.,
1983; Padilla et al., 1983; Priestman & Baum, 1976; Presant
et al., 1981; Selby et al., 1984; De Haas & Van
Knippenburg, 1985). The question is no longer whether these
factors should be measured, but what is the most reliable
and practical means of obtaining these essential data.
Oncologists routinely assess patients' physical fitness using
scales such as the Karnofsky (Karnofsky & Burchenal, 1949)
and these have been shown to correlate well with the patient
survival (Greico & Long, 1984). It would, theoretically, be
desirable to extend these scales to include psychological
factors such as anxiety, depression, the ability to socialise
and the extent to which an individual achieves his/her
expectations (Calman, 1984; Slevin, 1984). In the past this
has often meant using long, difficult forms, which are
impractical in anything other than a research environment.
However, instruments have now been designed to evaluate
these factors which can be completed by the doctor in a
matter of minutes (Spitzer et al., 1981; Morrow et al., 1978).
This approach fits in with current medical practice, and
could be extended to more general use.
To determine whether assessments of quality of life by
health professionals are meaningful and reliable, it is
necessary to examine the correlation between the scores
obtained by the health professionals and the final arbiters -
the patients themselves. It is also essential to examine the
degree of variability between the different health pro-
fessionals, as patients will often be seen by several doctors
and nurses during their illness.
Instruments and patients
The instruments used in this study were the Karnofsky
performance scale (Karnofsky & Burchenal, 1949), the
Spitzer quality of life evaluation (Spitzer et al., 1981), the
hospital anxiety and depression (HAD) scale (Zigmond &
Snaith, 1983), and a series of linear analogue self assessment
scales (LASA Scales) for quality of life, anxiety and
depression (Spitzer et al., 1981; Aitken, 1969). In addition
rating scales designed for this study giving four possible
options from very good through to very bad for quality of
life, anxiety and depression were used. The 10-point
Karnofsky scale measures the extent to which a patient's
symptoms restrict their activity and necessitate medical care.
The Spitzer scale measures five specific aspects of quality of
life, viz. activity, daily living, health, support and outlook,
with a choice of three possible answers for each. The HAD
scale measures seven different aspects of both anxiety and
depression, with a choice of four possible answers for each.
The same questionnaires were completed by the health
professionals, patients and relatives, with the exception that
the Karnofsky performance score was filled in only by the
health professionals and HAD scales were filled in only by
the patients.
The patients were a mixture of males and females from a
wide age range and social background. Many of them had
advanced malignant disease, predominantly of the lung,
ovary and breast, while some had just recently been
diagnosed. Many of the patients had received cytotoxic
chemotherapy at some point in their treatment.
Use ofinstruments
The questionnaires were completed by 108 patients and their
doctors at the same time. On 50 occasions, when a relative
was present, they also completed the questionnaires.
Two different groups of 25 patients filled in the same
forms on a single day, and daily for 5 consecutive days,
during a time when their clinical state was judged not to
have changed, and they had not received treatment likely to
cause upset. A further 25 patients were independently
evaluated on one occasion by five health professionals
closely involved in their case. This usually consisted of 2
doctors and 3 nurses.
Statistical analysis
Correlations, where given, are Kendall's correlation
coefficients (Kendall, 1948). All the correlation coefficients
given in the results are significant (P<0.01) and therefore
represent correlations that are unlikely to have occurred by
chance. Associations between the patients' assessment of
their quality of life, anxiety and depression during the test-
retest evaluation and between the five different health
professionals were measured using Kendall's concordance
coefficient (Kendall, 1948). This gives a number between
zero, for no association, and plus 1 for identical ordering of
the scores on each of the five occasions. To demonstrate
what this means in terms of the range (numerically) of
variability in the scores, Table III shows the percentage of
times the same score, and the same score +1 was achieved.
This needs to be taken in conjunction with the number of
options actually represented on the scale, and these are also
given in Table III.
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Results
The correlations for those scales filled in by both the doctors
and the patients and relatives are given in Table I. The
correlations are poor for the three factors measured, quality
of life, anxiety and depression. In fact the results obtained
by the health professionals rarely explained more than 30%
of the variability in the patients' scores with any of the
scales.
Correlations between the different scales when filled in by
the health professionals, and the same scales when filled in
by the patients, with particular reference to the Karnofsky
scale, are given in Table II. Correlations between the
doctors' different measures were higher than correlations
between the doctors' and patients' measures, suggesting at
least some consistency in the doctors' evaluations.
The variability in each of the scales when filled in
repeatedly by the patients and by different doctors and
nurses is shown in Tables III and IV. Table III gives the
percentage of times the same score was obtained on each of
the five occasions in the three groups, and the percentages
when the same score +1 was obtained. In order to make
meaningful comparisons between the LASA and Spitzer
scales, and the LASA and four-point scales using this
method, the LASA scale was divided into eleven and four
equal parts before comparison. This adaptation of the LASA
scale was called the interval LASA scale. Table IV gives a
statistical measure of the variability, viz. Kendall's
concordance coefficient. These tables show that there was
much greater variability in the doctors' scores than in those
of the patients. It is also apparent that while the variability
within the LASA and four point scales is similar, suggesting
that the scales are equally reproducible, the Karnofsky scale
demonstrated greater reproducibility than any of the other
scales filled out by the health professionals.
The health professionals' scores were also examined for
differences between the different assessors, and particularly
for differences between doctors and nurses. No statistically
significant differences were found.
The Spitzer and HAD scales were examined to see to what
extent their individual components were contributing to the
total score, and thus to determine whether all the questions
were useful and/or necessary. For the Spitzer, daily living,
activity and health each had a correlation coefficient of 0.8
with the total score, and thus each on its own could explain
64% of the total variability in this score. Using all three
Table I LASA and FPS' correlations (Kendall's T)
Patient vs. Patient vs. Doctor vs.
doctor (n =100) relative (n =50) relative (n =50)
LASA FPS LASA FPS LASA FPS
QOL 0.31 0.39 0.50 0.53 0.38 0.58
Anxiety 0.36 0.50 0.41 0.54 0.34 0.48
Depression 0.35 0.47 0.52 0.54 0.29 0.42
aFPS= Four point scale.
Table II Karnofsky correlations (Kendall's v)
Karnofsky vs:
Doctors Spitzer 0.65
Doctors QOL LASA 0.64
Patient Spitzer 0.49
Patient QOL LASA 0.30
Relative Spitzer 0.66
Relative QOL LASA 0.41
Correlations are based on -100 values
except where they include relatives, when they
are based on - 50 values.
together 93% of the variability could be explained, leaving
the outlook and support questions explaining only 7% of the
variability. The HAD scale comprises 14 questions relating
to aspects of anxiety and depression. For anxiety one
question, viz. the extent to which worrying thoughts
occupied the patient's mind, contributed 70% of the total
variability, and also had easily the highest correlation
coefficient with the four point scale on anxiety (X=0.57).
Using just 3 of the 7 questions 88% of the variability in the
total score could be obtained. A similar situation prevailed
for depression, with a question on the extent to which the
patient looked forward to things with enjoyment
contributing 64% of the variability and correlating highly
with the four point scale on depression (T=0.56). Overall,
correlations between the HAD scale and the other measures
of anxiety and depression were poor, as can be seen in
Table V.
Discussion
Two important points emerge from this study. Firstly it is
clear that the doctors could not adequately measure the
patients' quality of life. Although there was a highly
statistically significant correlation between the scores of the
doctor and those of the patient, the doctors' scores rarely
explained more than 30% of the variability in the patients'
scores (Table I). Quality of life is a concept that includes
many subjective elements, and it is therefore perhaps not
surprising that a doctor may not have the necessary
knowledge of the patient's feelings to evaluate their quality
of life accurately. The second point to emerge from the study
is the wide variability observed in the scores produced by the
different doctors and health professionals (Tables III & IV).
Even for the supposedly objective Karnofsky score, the same
score was achieved on only 54% of occasions, despite the
fact that only the top five points on this scale were covered.
For the other more subjective scales measuring quality of
life, anxiety and depression, the range of scores was even
greater, and thus even less reliable. These two points suggest
very strongly that if measurement of a patient's quality of
life is required, it should be done by the patients themselves
and not their doctors and nurses.
Why have these conclusions not been reached before? This
study specifically addressed the possibility of there being
differences between patients and doctors, but that is only
part of the answer. Misinterpretation of statistics provides
another part. It is a mistake to conclude that where a
statistically significant correlation is found between two
variables, they are measuring even approximately the same
thing. The P-value is relatively unimportant when analysing
correlations, except where numbers are very small. The
magnitude of the correlation coefficient, which in this study
reflects the degree of similarity of the scales being compared,
is much more important. Even with a seemingly 'good'
correlation coefficient of, say, 0.7 only 50% of the variability
in one set of scores is explained by the other. Thus
differences between scales can be easily overlooked.
The variability in results from repeated testing calls into
question the reliability of the instruments used. The
validation of these instruments (Gough et al., 1983; Selby et
al., 1984; Spitzer et al., 1981) was done on two occasions,
and the interrater variability was looked at with two health
professionals. While the patients' repeated scores suggest that
the instruments can be filled in consistently, the interrater
variability casts doubt on their reliability for use by health
professionals.
Some further points of interest were noted with the HAD
and Spitzer scales. The poor correlation of the HAD scale
with the more direct measures of anxiety and depression
using the LASA and four point scales suggest that, in cancer
patients at least, the elements of the HAD scale are not the
major contributors to anxiety and depression. The mainMEASURING QUALITY OF LIFE 111
Table III Patient test-retest evaluation and interrater agreement between 5 health
professionals using the different scales
Patients
Number of
points on 5 times in Dailyfor 5 health
scale I day 5 days professionals
HAD (ANX) 7 60 (83) 69 (86)
HAD (DEP) 7 69 (86) 63 (86)
FPS' (QOL) 4 90 (99) 88 (100) 73 (99)
4-interval (QOL) LASA 4 90 (100) 87 (97) 62 (90)
FPSa (ANX) 4 93 (100) 85 (100) 66 (93)
4-interval (ANX) LASA 4 82 (96) 82 (96) 64 (90)
FPS' (DEP) 4 95 (100) 89 (100) 67 (99)
4-interval (DEP) LASA 4 84 (95) 86 (95) 58 (95)
Spitzer 11 78 (97) 80 (95) 45 (70)
11-interval LASA 11 63 (95) 68 (89) 46 (69)
Karnofsky 10 54 (90)b
aFPS =Four point scale; brepresents same score + 10. (Figures are % of times same
score was achieved, figures in parentheses represent % of times the same score + 1
was achieved.)
Table IV Patient test-retest evaluation and interrater agreement between 5 health professionals using
Kendall's concordance coefficient
LASA Four point scale
Spitzer ANX DEP QOL ANX DEP QOL Karnofsky
5 x One day 0.94 0.85 0.82 0.94 0.93 0.95 0.89 patient Daily % days 0.88 0.83 0.75 0.81 0.78 0.83 0.80J a
5 health professionals 0.54 0.45 0.48 0.46 0.39 0.49 0.54 0.72
Table V HAD correlations (Kendall's i)
HAD (Anxiety) vs:
Patient anxiety LASA 0.47
Patient anxiety FPS' 0.60
Doctors anxiety LASA 0.39
Doctors anxiety FPS' 0.48
HAD (Depression) vs:
Patient depression LASA 0.49
Patient depression FPS' 0.57
Doctors depression LASA 0.41
Doctors depression FPSa 0.46
aFPS=Four point scale; Correlations are
based on - 100 values.
contributing elements in the HAD scale, worry and the
inability to look forward to things, suggest that the cancer
patient is anxious and worried chiefly because of worry
about his/her future, and perhaps this problem area could be
addressed more directly. The Spitzer scale appears to present
a similar picture of inappropriate questions.
It is of interest that the LASA scale showed similar con-
cordance coefficients when taken as measured, compared
with being divided into four equal parts for comparison with
the four point scale (Table IV). It seems likely that the
continuous scale is no more sensitive than the simple four
point scale.
A degree of caution needs to be exercised when
interpreting the results of a study such as this. The
population under consideration includes a variety of
different cancer types, stages of disease, and different
treatment protocols. It is unlikely that the instruments would
perform in the same predictable way across all these groups.
However, part of the reason for such a study is to discover if
the instruments can be reliable and useful in this field. The
clear differences between the doctors' and patients'
evaluations suggests that doctors using these scales are
unlikely to accurately determine what the patients felt.
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